DWM
MRNA icon

Dakota Wealth Management’s Moderna MRNA Stock Holding History

Dakota Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,254
Closed -$386K – 756
2024
Q2 		$386K Buy
3,254
+7
+0.2% +$886 0.01% 542
2024
Q1 		$346K Buy
+3,247
New +$327K 0.01% 560
2022
Q1 		– Sell
-995
Closed -$253K – 473
2021
Q4 		$253K Sell
995
-15,650
-94% -$4.58M 0.03% 325
2021
Q3 		$6.41M Buy
+16,645
New +$6.14M 0.74% 34

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dakota Wealth Management's MRNA Position: Q3 2024 in Review

Dakota Wealth Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 3,254 shares — an estimated $386K sold.

Dakota Wealth Management first reported a position in MRNA in Q3 2021 and held it in 4 quarters. The position peaked at $6.41M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Dakota Wealth Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Dakota Wealth Management sold 3,254 Moderna shares in Q3 2024, an estimated $386K.
  • Dakota Wealth Management first reported a position in Moderna in Q3 2021 and held it in 4 quarters.
  • Dakota Wealth Management's Moderna position peaked at $6.41M in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Dakota Wealth Management's 13F filing for Q3 2024, filed 23 Oct 2024.